The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000314.6(PTEN):c.-1059C>G

CA300594

189520 (ClinVar)

Gene: KLLN
Condition: PTEN hamartoma tumor syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 271c91d3-d627-42bf-86bc-ba9a7f7f2189

HGVS expressions

NM_000314.6:c.-1059C>G
NM_000314.6(PTEN):c.-1059C>G
NC_000010.11:g.87863410C>G
CM000672.2:g.87863410C>G
NC_000010.10:g.89623167C>G
CM000672.1:g.89623167C>G
NC_000010.9:g.89613147C>G
NG_007466.2:g.4973C>G
NG_033079.1:g.5028G>C
NM_001126049.1:c.-923G>C
ENST00000371953.7:c.-1060C>G
ENST00000445946.3:c.-923G>C

Benign

Met criteria codes 1
BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
PTEN VCEP
PTEN c.-1059C>G (NC_000010.10:g.89623167C>G) meets criteria to be classified as benign for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (Mester et al. 2018; manuscript in preparation). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column). BA1: Allele frequency of 0.0138 (1.38%, 120/8698 alleles) in the African subpopulation of the gnomAD cohort. (PMID 27535533)
Met criteria codes
BA1
BA1: Allele frequency of 0.0138 (1.38%, 120/8698 alleles) in the African subpopulation of the gnomAD cohort. (PMID 27535533)
Approved on: 2016-09-14
Published on: 2018-12-10
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.